Undertaking Studies to Inform Public Policy: Managing Data Collection to Ensure Data Quality in the EQ-5D-5L UK Valuation Through the Use of Independent Quality Control Assessments

Author(s)

Rowen D1, Mukuria C1, Cooper S2, Bray N3, Carlton J4, Longworth L5, Meads D6, Oluboyede Y7, O'Neill C8, Yang Y9
1University of Sheffield, Sheffield, South Yorkshire, UK, 2National Institute for Health and Care Excellence, London, UK, 3Bangor University, Bangor, UK, 4University of Sheffield, Sheffield, UK, 5Putnam PHMR Ltd., London, UK, 6University of Leeds, Leeds, UK, 7Putnam PHMR Ltd., Newcastle Upon Tyne, NT, UK, 8Queen's University Belfast, Belfast, UK, 9University of Oxford, Oxford, UK

Presentation Documents

OBJECTIVES: Research studies used to inform public policy should be rigorous, well-conducted and transparent. Primary data and analyses can be assessed once the study is complete, but at that point raw data quality cannot be improved. The UK valuation of EQ-5D-5L, which is urgently required to inform policy including health technology assessments submitted to NICE (National Institute for Health and Care Excellence,) is using in-built independent data quality assessments during primary data collection to make ongoing assessments of quality.

METHODS: Twelve hundred interviews are being undertaken using the time trade-off elicitation technique, using the EQ-VT (EuroQol Valuation Technology) interviewing system (version 2.1) with a representative sample of the UK population. The study benefits from public involvement and input from EuroQol’s EQ-VT support team, an independent Quality Control team and a Steering Group. The EQ-VT support team undertake weekly data monitoring at the aggregate and interviewer level throughout data collection to monitor data quality and identify issues. The Quality Control team independently assess the data at pilot stage, 20%, 40% and 60% data collection, and assess the final dataset and analyses. At each of these stages the decision to continue and/or refine data collection is made by the Steering Group, comprised of representatives from NICE, National Health Service (NHS) England, Department of Health and Social Care (DHSC), international experts and EuroQol scientific leaders.

RESULTS: Following a successful pilot, over 60% data collection has been undertaken, with no substantial modifications to data collection required. All interim analyses have indicated that data quality is acceptable. Data collection is ongoing.

CONCLUSIONS: Independent assessments of primary data during its collection can be undertaken to identify any issues arising promptly. This enables amendments to be made during data collection, where changes are possible, rather than finding the data has unresolvable issues once data collection is complete.

Conference/Value in Health Info

2023-11, ISPOR Europe 2023, Copenhagen, Denmark

Value in Health, Volume 26, Issue 11, S2 (December 2023)

Code

HTA213

Topic

Methodological & Statistical Research

Topic Subcategory

PRO & Related Methods, Survey Methods

Disease

No Additional Disease & Conditions/Specialized Treatment Areas

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×